Send to

Choose Destination
Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e325. doi: 10.1212/NXI.0000000000000325. eCollection 2017 Mar.

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS.

Author information

Institute of Neuroimmunology and Multiple Sclerosis (S.C.H., K.H.S., M.A.F., C.H.), Department of Neurology (S.C.H., K.H.S., C.H.), and Department of Diagnostic and Interventional Neuroradiology (B.H.), University Medical Center Hamburg-Eppendorf; and Neurological Private Practice (V.B., B.E.), Hamburg, Germany.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center